Agile Therapeutics, Inc. (AGRX)

Agile Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-14.47	-25.41	-76.59	-54.69	-18.44
Depreciation & Amortization	0.39	1.53	2.22	0.28	0.16
Share-Based Compensation	1.98	2.49	3.34	2.82	1.76
Other Operating Activities	2.52	-14.56	5.82	4.28	0.83
Operating Cash Flow	-9.58	-35.95	-65.2	-47.31	-15.69
Capital Expenditures	0	-0.13	-0.27	-0.35	-0.1
Acquisitions	0	0	0	0.35	0
Change in Investments	-	-	-39.73	-69.34	-
Other Investing Activities	-	-	79.46	28.65	-
Investing Cash Flow	0	-0.13	39.46	-40.69	-0.1
Common Stock Issued	8.24	35.43	30.35	49.04	42.25
Other Financing Activities	-1.35	-13.25	0.08	18.94	0.16
Financing Cash Flow	6.89	22.18	30.42	67.99	42.42
Net Cash Flow	-2.69	-13.9	4.68	-20.02	26.63
Free Cash Flow	-9.58	-36.08	-65.47	-47.66	-15.79
Free Cash Flow Margin	-48.88%	-331.50%	-1596.46%	-6363.68%	-
Free Cash Flow Per Share	-4.44	-83.48	-53956.18	-1125.72	-638.74

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.